These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15869456)

  • 21. Selective internal radiotherapy (SIRT) of hepatic tumors: how to deal with the cystic artery.
    Theysohn JM; Müller S; Schlaak JF; Ertle J; Schlosser TW; Bockisch A; Lauenstein TC
    Cardiovasc Intervent Radiol; 2013 Aug; 36(4):1015-22. PubMed ID: 22983697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging.
    Lewandowski RJ; Thurston KG; Goin JE; Wong CY; Gates VL; Van Buskirk M; Geschwind JF; Salem R
    J Vasc Interv Radiol; 2005 Dec; 16(12):1641-51. PubMed ID: 16371530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma.
    Rhee TK; Omary RA; Gates V; Mounajjed T; Larson AC; Barakat O; Sato KT; Mulcahy M; Gordon S; Lewandowski RJ; Salem R
    J Vasc Interv Radiol; 2005 Aug; 16(8):1085-91. PubMed ID: 16105920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Yttrium-90 microsphere-selective internal radiation therapy with chemotherapy (chemo-SIRT) for colorectal cancer liver metastases: an in vivo double-arm-controlled phase II trial.
    Gulec SA; Pennington K; Wheeler J; Barot TC; Suthar RR; Hall M; Schwartzentruber D
    Am J Clin Oncol; 2013 Oct; 36(5):455-60. PubMed ID: 22643569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres.
    Dancey JE; Shepherd FA; Paul K; Sniderman KW; Houle S; Gabrys J; Hendler AL; Goin JE
    J Nucl Med; 2000 Oct; 41(10):1673-81. PubMed ID: 11037997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective internal radiation therapy with 90Y microspheres for colorectal liver metastases: single-centre experience with 100 patients.
    Stubbs RS; O'Brien I; Correia MM
    ANZ J Surg; 2006 Aug; 76(8):696-703. PubMed ID: 16916386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radioembolization in patients with hepatic metastases from breast cancer.
    Jakobs TF; Hoffmann RT; Fischer T; Stemmler HJ; Tatsch K; La Fougere C; Murthy R; Reiser MF; Helmberger TK
    J Vasc Interv Radiol; 2008 May; 19(5):683-90. PubMed ID: 18440456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective study of treatment with selective internal radiation therapy spheres in patients with unresectable primary or secondary hepatic malignancies.
    Lim L; Gibbs P; Yip D; Shapiro JD; Dowling R; Smith D; Little A; Bailey W; Liechtenstein M
    Intern Med J; 2005 Apr; 35(4):222-7. PubMed ID: 15836500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective internal radiation therapy with 90yttrium microspheres for extensive colorectal liver metastases.
    Stubbs RS; Cannan RJ; Mitchell AW
    J Gastrointest Surg; 2001; 5(3):294-302. PubMed ID: 11360053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catheter-Directed Computed Tomography Hepatic Angiography for Yttrium-90 Selective Internal Radiotherapy of Hepatocellular Carcinoma Reduces Prophylactic Embolization of Extrahepatic Vessels.
    Goh WXT; Leong S; Too CW; Cheng LT; Saffari SE; Lee RZ; Ng STS; Lo RHG; Tay KH; Chan SXJM; Gogna A; Irani FG; Venkatanarasimha N; Loke KSH; Chow PKH; Ng DCE; Urlings TAJ; Patel A; Damodharan K; Toh LHW; Tan BS
    Cardiovasc Intervent Radiol; 2020 Mar; 43(3):478-487. PubMed ID: 31705243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FDG PET for monitoring response to local and locoregional therapy in HCC and liver metastases.
    Dierckx R; Maes A; Peeters M; Van De Wiele C
    Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):336-42. PubMed ID: 19521313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and toxicity related to treatment of hepatocellular carcinoma with 90Y-SIR spheres: radiobiologic considerations.
    Strigari L; Sciuto R; Rea S; Carpanese L; Pizzi G; Soriani A; Iaccarino G; Benassi M; Ettorre GM; Maini CL
    J Nucl Med; 2010 Sep; 51(9):1377-85. PubMed ID: 20720056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management and prevention of adverse effects related to treatment of liver tumours with 90Y microspheres.
    Szyszko T; Al-Nahhas A; Tait P; Rubello D; Canelo R; Habib N; Jiao L; Wasan H; Bansi D; Thillainayagam A; Nijran K; Stamp G; O'Rourke E
    Nucl Med Commun; 2007 Jan; 28(1):21-4. PubMed ID: 17159545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors for prediction of survival of hepatocellular cancer patients after selective internal radiation therapy.
    Soydal C; Keskin O; Kucuk ON; Ozkan E; Bilgic S; Idilman R; Kir MK
    Ann Nucl Med; 2015 Jun; 29(5):426-30. PubMed ID: 25783289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can pretreatment hepatic artery perfusion scintigraphy in patients with liver malignancies predict the treatment response of the selective internal radiation therapy with 90Y resin microspheres?
    Guney IB; Balli HT; Kucuker KA; Unal I; Kibar M
    Diagn Interv Radiol; 2022 Mar; 28(2):156-165. PubMed ID: 35548900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The toxicity of liver directed yttrium-90 microspheres in primary and metastatic liver tumors.
    Neff R; Abdel-Misih R; Khatri J; Dignazio M; Garcia M; Petrelli N; Wilson P
    Cancer Invest; 2008 Mar; 26(2):173-7. PubMed ID: 18259948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimization of radioembolic effect with extended-shelf-life yttrium-90 microspheres: results from a pilot study.
    Lewandowski RJ; Riaz A; Ryu RK; Mulcahy MF; Sato KT; Kulik LM; Gates VL; Baker T; Omary R; Salem R
    J Vasc Interv Radiol; 2009 Dec; 20(12):1557-63. PubMed ID: 19854068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic importance of 18F-FDG uptake pattern of hepatocellular cancer patients who received SIRT.
    Kucuk ON; Soydal C; Araz M; Bilgic S; Ibis E
    Clin Nucl Med; 2013 Jul; 38(7):e283-9. PubMed ID: 23531737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiography-based C-arm CT for the assessment of extrahepatic shunting before radioembolization.
    Heusner TA; Hamami ME; Ertle J; Hahn S; Poeppel T; Hilgard P; Bockisch A; Forsting M; Antoch G
    Rofo; 2010 Jul; 182(7):603-8. PubMed ID: 20183775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extra-hepatic embolisation of Y-90 microspheres from selective internal radiation therapy (SIRT) of the liver.
    Thamboo Tp; Tan KB; Wang SC; Salto-Tellez M
    Pathology; 2003 Aug; 35(4):351-3. PubMed ID: 12959774
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.